Introduction {#sec1-1}
============

In 2005, the prevalence of amputees in the United States was \~1 in 190\[[@ref1]\]. That prevalence is expected to double by 2050. Direct skeletal attachment of limb prostheses via percutaneous osseointegrated implants is an emerging alternative to socket prostheses, with several advantages that improve overall quality of life\[[@ref2]\]; especially for patients with short residuum and high soft-tissue volume\[[@ref3]\]. Implants directly connected to living bone in amputated limbs allows for a more stable connection enabling greater control of the prosthesis and heightened osseoperception (sensory feedback from the environment)\[[@ref4]\] while eliminating problems associated with socket-devices such as painful skin lesions and irritations\[[@ref5]\].

Direct osseointegration of metal implants has been shown to be a viable long-term solution for connection to the skeletal system but requires reduced loads during the healing period\[[@ref3],[@ref6],[@ref7]\]. Implant coatings and metal porosity are being studied to reduce infection and promote osseointegration\[[@ref8],[@ref9]\]. However, fibrous encapsulation of osseointegrated implants still occurs, impairing long-term implant stability\[[@ref10],[@ref11]\]. Premature loading of osseointegrated implants before complete bone-implant osseointegration can lead to excessive micromotion\[[@ref12],[@ref13]\] which in turn may result in fibrous ingrowth instead of bone ingrowth\[[@ref14]\]. To avoid fibrous ingrowth into the implant resulting from excessive loading and micromotion, controlled and gradual rehabilitation occurs over a 12-month period\[[@ref15]\]. It is critical to identify methods of accelerating osseointegation and therefore to shortening the rehabilitation period while also lessening the likelihood of fibrous ingrowth.

Low-magnitude, high-frequency (LMHF) whole body vibration (WBV) and low-intensity pulsed ultrasound (LIPUS) are two methods that show promise for accelerating osseointegration. Previous studies investigating fracture healing have indicated that both therapies are beneficial to bone healing through mechanisms not clearly defined\[[@ref16]-[@ref18]\]. The range of in WBV amplitudes that stimulate osseointegration has been reported\[[@ref19],[@ref20]\]. Local application of vibration has not been previously investigated as a means of accelerating intramedullary implant osseointegration. However, local application of vibration may be is preferable to WBV clinically in order to reduce the risk of adverse responses that might occur with whole body exposure such as back pain and Raynaud's syndrome\[[@ref21]\]. In the current study, an optimal vibration amplitude of 0.6 g peak acceleration identified in an earlier WBV study was used as the basis for locally applied vibration.

While past studies have shown LIPUS is able to accelerate osseointegration in transverse implantation models\[[@ref22],[@ref23]\], it is unclear whether sufficient stimulus can reach the endosteal surfaces to improve implant stability in a more clinically relevant intramedullary implantation model\[[@ref24]\]. Therefore, an intramedullary implant model was used in this study to evaluate the efficacy of LIPUS treatment in accelerating osseointegration.

The combined effect of locally applied vibration and LIPUS on osseointegration has not been previously investigated, and thus, these therapies were combined in this study to determine if their potential stimulatory effects on osseointegration were additive.

The objective of this study was to determine if locally applied LMHF vibration or LIPUS would accelerate osseointegration of the bone-implant interface and improve peri-implant bone volume at 4 and 8 weeks. We hypothesized that each therapy would improve osseointegration and peri-implant bone volume and that when the therapies were combined their effects on osseointegration would be additive.

Materials and methods {#sec1-2}
=====================

A 4-week-long *in vivo* study was performed to determine early osseointegration characteristics of control, LIPUS and local vibration in a bilateral intramedullary femoral implant model. A subsequent 8-week study was conducted to determine further osseointegration and the combined effects of the treatments. Bone ongrowth was evaluated using mechanical pushout, µCT and histomorphometry for both studies. All animal work was carried out in accordance to the Animal Research: Reporting of *In-Vivo* Experiments (ARRIVE) guidelines and approved by the local Institutional Animal Care and Use Committee (IACUC). Female retired breeder (mean age= 24 weeks) Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) were given *ad libitum* access to food and water with a 12-hr light/dark cycle (7AM -- 7PM).

Based on previous intramedullary implantation rat studies\[[@ref25]\], a standard deviation of 25% of the mean pushout strength was estimated. To detect a 40% difference in strength between the 3 treatment groups of the 4-week study with a power of 0.80 and an alpha of 0.05, power analysis calculated an N of 9 rats. To compensate for the potential loss of animals due to surgical complications, each group included 10 rats. The power analysis calculated an N of 10 rats to detect the same difference in strength between the four treatment groups of the 8-week study. Due to confidence in surgical outcomes achieved during the 4-week study, each group included 10 rats. Based on previous experience with µCT results\[[@ref26]\], an N of 8 and 9 for the 4 and 8-week studies respectively was calculated using the prior power analysis with a detectable difference of 35% and standard deviation of 20%.

Implant model {#sec2-1}
-------------

Biocompatible, grade 5 titanium, 20-mm-long and 1.5-mm-diameter implants were fabricated with a 1.6-mm boss on their last 1.5 mm and a dimple in each end to facilitate surgical implantation and mechanical pushout\[[@ref26]\]. The implants were additively manufactured, textured by acid etching, optically evaluated and handled identically to the intramedullary implants of a prior study\[[@ref26]\]. The implants had a mean ± SD surface roughness\[[@ref25]\] of Ra= 10±0.3 µm.

Surgical model {#sec2-2}
--------------

On the day of surgery, each rat received bilateral femoral implants. The distal femurs were exposed as described previously\[[@ref27]\]. An 18-gauge needle was used to start a hole in the intercondylar notch while the final hole was reamed and extended to a 21-mm depth manually with a 1.5-mm twist bit without irrigation\[[@ref28]\]. The implant was inserted by manual thrust and torque into the drilled hole until flush with the articular surface. The joint capsule was closed with 4-0 polyglactin 910 suture\[[@ref29]\]. The incision was closed using wound clips (Autoclips, MikRon Precision Inc, Gardena, CA) and tissue adhesive (TA5, Med Vet International, Mettawa, IL). Each rat was given a subcutaneous injection of 0.5 mg/kg buprenorphine SR and 0.15 mL ceftriaxone preoperatively for amelioration of postsurgical pain and to prevent infection, respectively. A 5-mL lactated ringer's subcutaneous injection was given to each animal following surgery. A 1.6 mg/mL acetaminophen solution was provided *ad libitum* for seven days post-surgery. Radiographs were acquired 12 days after surgery to confirm proper implant placement and thereupon wound clips were removed.

Treatments {#sec2-3}
----------

A dual-limb local vibration stimulator was constructed from a pair of electromagnetic minishakers (Brüel & Kjær, Nærum, Denmark), a signal generator and an amplifier. The output amplitude of the local 45 Hz vibration system was tuned so the magnitude of vibration at the femur matched the 0.6 g peak acceleration for the optimal *in vivo* WBV amplitude of prior work\[[@ref19]\].

After implantation surgeries, animals in the 4-week study were randomly divided into three groups: control, LIPUS, and LMHF vibration to maintain uniform mean body weights between groups. Animals in the 8-week study were divided into four groups: control, LIPUS, vibration, and combined LIPUS/vibration as applied above. Treatments were started seven days after surgery and rats received treatment 20 min per day, five days per week\[[@ref25]\]. All animals were secured in a custom rat restraint system while under isoflurane inhalation induced anesthesia and then allowed to awaken to position the knees in a flexed and externally rotated presentation ([Figure 1](#F1){ref-type="fig"}). Once conscious, the designated 20-minute treatment was initiated (control, vibration or LIPUS). The vibration stimulus was directly applied bilaterally to the knee joints, minimizing dampening effects from surrounding soft tissue. A LIPUS applicator (Exogen 4000+, Bioventus, Durham, NC) was centered over the approximated mid-point of the implant on each limb. Neither LIPUS nor locally applied vibration has been approved by the FDA for this therapy mode. The control was secured with a polyacetal disc for 20 minutes simulating the LIPUS applicator. Rats quickly became accustomed to the restraint and struggled minimally (\<2 min) during the initial days of treatment. At the completion of each treatment, rats were removed from restraints, returned to their cage and fed a sweetened cereal (Froot Loops, Kellogg's, Battle Creek, Michigan, US) to reduce stress post restraint and prevent stress-associated weight loss\[[@ref30],[@ref31]\].

![Rat in custom restraint system undergoing locally applied vibration treatment.](JMNI-19-150-g001){#F1}

After the 4 and 8 week rehabilitation periods, the animals were humanely euthanized by C0~2~ overdose followed by thoracotomy. The right femurs were collected, wrapped in saline soaked gauze and stored at -20°C until mechanical testing. The contralateral limb, used for µCT and histology, was fixed in 70% ethanol at the time of dissection.

Mechanical testing {#sec2-4}
------------------

Mechanical push-out testing, evaluating the bone-implant stiffness; maximum load to bone-implant failure; and energy to failure, was performed to assess osseointegration as done in a prior study\[[@ref26]\]. The proximal femur was removed to allow pushout of implants and the residual specimen potted using a self-curing acrylic resin (Ortho Jet BCA, Lang Dental, Wheeling, IL) as previously described\[[@ref26]\].

Mechanical testing was carried out with a material testing system (MTS) (8500 Plus, Instron Corp., Norwood, MA). The linear load of the MTS was transferred to the implant through a tapered stainless steel pin and measured with a 1kN load cell. Specimens were preloaded to 5 N and pushed at a constant rate of 2 mm/min until failure of the bone-implant interface.

Ex-vivo µCT {#sec2-5}
-----------

Osseointegration was evaluated by bone volume fraction (BV/TV) along a 2.5 mm length, 2 mm from the proximal end and along 6 mm, 1.5 mm from the distal end of the implant ([Figure 2](#F2){ref-type="fig"}) using µCT to assess a predominantly cortical region versus a cancellous bone region, respectively\[[@ref32]\]. Femurs were scanned on equipment (40 model specimen CT, Scanco Medical, Brüttisellen, Switzerland) with settings (70 kVp, 114 µA, and 8 W) as described\[[@ref33]\] with a 10-mm field of view on "medium resolution" with a cubic voxel size of 12 µm. The proximal end of the femur of each specimen was removed using a fine-toothed rotary bone saw 1 mm proximal to the implant to facilitate placement in the µCT x-ray tube as well as subsequent infiltration of methacrylate resin.

![Regions of interest for µCT evaluation of bone volume fraction (BV/TV) in a predominantly cortical region versus a cancellous region.](JMNI-19-150-g002){#F2}

The µCT scans were analyzed using medical image processing software (Mimics 16.0, Materialise, Plymouth, MI). The implant was dilated by five pixels (60 µm) to exclude the metal-induced artifact as determined previously\[[@ref33]\]. The bone was segmented out using low and high thresholds of 529 and 1615 mg HA/cm^3^, respectively. Implants were segmented using a threshold ≥2249 mg HA/cm^3^.

The BV/TV within 250 µm of the implant was calculated\[[@ref20]\]. Due to a distinct cortical shell seen in the proximal scans, the cortical shell was excluded from BV/TV calculations ([Figure 2](#F2){ref-type="fig"}). However, the cortical region near the epiphyseal line was less distinct and was included in analyses of the distal regions. BV/TV calculations were limited to the region proximal to the epiphyseal line because the transition from bone to cartilage made BV/TV calculations distal to the epiphyseal line not possible\[[@ref32]\]. Bone-implant contact (BIC) was not calculated due to the dilation of the implant removing the actual interface. Measurements of BIC through µCT were unreliable in a previous study\[[@ref33]\]. Other architectural parameters were not evaluated as they are often correlated with the BV/TV and may result in a type I error of detecting a difference when there is not.

Histological staining {#sec2-6}
---------------------

Femurs were dehydrated with ethanol, stripped of lipids with acetone and embedded in methacrylate resin (Technovit 7200 VLC, EXAKT, Oklahoma City, OK, US) under constant agitation via a stir bar in a vacuum desiccator after µCT scanning. Following infiltration, the specimens, secured in molds at each end of the implant with a custom fixture maintaining cranial-caudal orientation along the implant axis at the midline of the mold cavity, were fully embedded in methacrylate resin. The specimens were sectioned, mounted to slides and polished to a 25-µm-thickness with a precision cutting/grinding system (EXAKT, Oklahoma City, OK, US)\[[@ref34]\]. The sectioning plane was defined by the axes of the implant and femoral notch. The longitudinal sections were then stained with acid fuchsine for 3 minutes\[[@ref35]\] and imaged through a 10x bright field lens with a two-second exposure on a microscope (Olympus BX51 with DP72 color camera). The resulting images ([Figure 3](#F3){ref-type="fig"}) were evaluated for percent BV/TV within 250 µm of the implant and BIC using imaging software (Fiji, imagej.net) along the entire implant, excluding the distal 1.5-mm-long boss.

![Digital image of acid fuchsine stained section of femur for histomorphometric evaluation.](JMNI-19-150-g003){#F3}

Statistical analysis {#sec2-7}
--------------------

One-way analysis of variance with Holm-Sidak mean comparison testing for all outcome measures was performed to assess treatment effects using a statistical analysis program (SigmaPlot v11.0, Systat Software Inc, San Jose, CA).

Results {#sec1-3}
=======

Radiographs confirmed the placement of bilateral implants and that no bone fractures occurred during implantation. No differences in weight change were noted between groups at either time point.

4-week evaluations {#sec2-8}
------------------

Maximum pushout load of implants increased for both LIPUS and vibration groups relative to the control group in the 4-week study (37.7% \[P=0.002\] and 20.2% respectively, [Figure 4](#F4){ref-type="fig"}) with the increase from vibration failing to reach statistical significance. Similarly, the energy to maximum load was increased by 74.5% for the LIPUS group relative to the control, while the vibration group was not found to differ from the control ([Table 1](#T1){ref-type="table"}). The stiffness of the bone-implant interface from the pushout test was not found to differ among any of the groups ([Table 1](#T1){ref-type="table"}).

![Mean and standard deviation of maximum load to failure of bone-implant interface of control, locally applied vibration and low-intensity pulsed ultrasound groups of 4 week study (N=10). \* notes significant difference.](JMNI-19-150-g004){#F4}

###### 

Mechanical and biological outcomes (mean ± SD) after surgical implantation of textured rods into rat femurs with adjunctive local vibration (Vibration), low-intensity pulsed ultrasound (LIPUS) or vibration and LIPUS (Combined). "a" differs significantly from "b" (P\<0.05). "N" represents the number of specimens tested for each treatment group. NA = not available.

                               Control            Vibration       LIPUS           Combined        
  ---------------------------- ------------------ --------------- --------------- --------------- ---------------
  **4 Week (N=10)**            Stiffness (N/mm)   1190±128        1211±92         1263±60         NA
  Max Load (N)                 248±53 ^a^         298±69          341±57 ^b^      NA              
  Energy (mJ)                  29.8±9.5 ^a^       42.9±17.3       52.0±11.2 ^b^   NA              
  **8 Week (N=10)**            Stiffness (N/mm)   1940±149        1944±362        2120±268 ^b^    1657±411 ^a^
  Max Load (N)                 423±52             433±104         439±101         437±32          
  Energy (mJ)                  51.0±10.5          55.7±21.9       57.7±25.3       70.0±18.7       
  **4 Week µCT (N=8)**         Prox. BV/TV        7.7±1.9%        6.6±2.3%        6.4±1.7%        NA
  Dist. BV/TV                  29.6±5.9% ^a^      34.7±5.2%       38.7±1.9% ^b^   NA              
  **8 Week µCT (N=9)**         Prox. BV/TV        6.6±5.2%        5.6±3.5%        4.9±4.3%        3.8±3.5%
  Dist. BV/TV                  27.8±8.4% ^a^      36.0±6.6% ^b^   27.2±3.6% ^a^   30.2±4.9%       
  **4 Week Histology (N=6)**   BV/TV              32.7±4.1%       35.1±5.8%       37.9±4.4%       NA
  BIC                          17.9±4.1% ^a^      25.4±4.5% ^b^   27.9±7.3% ^b^   NA              
  **8 Week Histology (N=6)**   BV/TV              35.3±3.5% ^a^   49.1±5.3% ^b^   33.0±7.4% ^a^   35.4±0.8% ^a^
  BIC                          31.4±5.7%          35.9±13.6%      30.0±3.9%       31.8±1.3%       

The µCT evaluation demonstrated that LIPUS significantly (30.7% \[P=0.003\]) improved peri-implant BV/TV in the metaphyseal (distal) region relative to the control group, while the vibration group was not found to differ from the control ([Table 1](#T1){ref-type="table"}). In contrast, no group differences were found in the peri-implant BV/TV in the diaphyseal (proximal) region for the µCT evaluation.

For the histological evaluation, no group differences were detected in the peri-implant BV/TV ([Table 1](#T1){ref-type="table"}). However, the histological evaluation of BIC did find significant \[P\<0.05\] improvements in bone ongrowth to the implant for both the LIPUS and vibration groups relative to the control (55.9% and 41.9% respectively, [Figure 5](#F5){ref-type="fig"}).

![Mean and standard deviation of % bone-implant contact revealed by acid fucshine staining of histological sections of 4 week Study (N=6). \* notes significant difference.](JMNI-19-150-g005){#F5}

8-week evaluations {#sec2-9}
------------------

Pushout testing at the 8-week time point revealed no individual treatment group differences relative to the control for the maximum pushout load, energy to maximum load, or stiffness ([Table 1](#T1){ref-type="table"}). Curiously, the combined LIPUS and vibration group was found to have significantly (21.8% \[P=0.003\]) decreased stiffness relative to the LIPUS alone group.

The µCT evaluation at 8 weeks at the metaphyseal region found the vibration group to have significantly improved peri-implant bone volume relative to either the control or LIPUS alone group (29.5% and 32.4% respectively \[P\<0.01\]). In contrast, no group differences were found in diaphyseal (proximal) region ([Table 1](#T1){ref-type="table"}).

For the histological evaluation peri-implant bone volume of the vibration alone group was significantly improved relative to all the remaining groups (25.7% average \[P\<0.001\], [Figure 6](#F6){ref-type="fig"}). However, the BIC by histological evaluation was not found to differ among the groups at 8 weeks ([Table 1](#T1){ref-type="table"}).

![Mean and standard deviation of bone-volume fraction revealed by acid fucshine staining of histological sections of 8 week study (N=6). \* notes significant difference.](JMNI-19-150-g006){#F6}

Discussion {#sec1-4}
==========

LIPUS has been shown to upregulate mRNAs involved in bone healing (alkaline phosphatase, osteocalcin, insulin-like growth factors and bone sialoprotein)\[[@ref36],[@ref37]\] and have a metabolic impact during all phases of bone healing\[[@ref38]\]. While prior LIPUS studies have shown increased bone formation around intramedullary implants, none have investigated the beneficial effects of LIPUS on intramedullary implant mechanical stability in animals including rats, rabbits and dogs\[[@ref22]-[@ref24],[@ref39]\]. This study demonstrates that LIPUS treatments result in accelerated bone healing and lead to improved osseointegration at 4 weeks with significantly increased axial load capabilities and energy to failure. These benefits are most likely a result of the increased bone surrounding the implant in the form of BV/TV seen through µCT and the BIC seen in histomorphometric evaluations of the acid fuchsine-stained specimens ([Table 1](#T1){ref-type="table"}). Interestingly, the therapeutic benefits to osseointegration were no longer detected after 8 weeks, possibly because the native biological bone healing process caught up, as seen in the histologic results in a prior study\[[@ref22]\]. For the implantation model used in the current study, an upper implant mechanical stability limit may be reached earlier with the LIPUS treatment compared to no treatment. The observed hastening of the bone-implant mechanical stability indicates that LIPUS appears to be a therapeutic tool for accelerating bone ingrowth and patient rehabilitation.

LMHF vibration has been demonstrated as a successful treatment for fracture healing with several animal studies showing increased callus formation\[[@ref16],[@ref17]\] and higher mineral content\[[@ref40]-[@ref42]\]. The dual limb local vibration stimulators of this study were tuned to deliver similar LMHF vibration to the implant site as an optimal WBV determined in a prior study. Histomorphometric evaluation revealed an increase in BIC by 4 weeks. Despite the improvement in BIC with vibration, the numerical increase in load to failure of the vibration group at 4 weeks did not reach statistical significance. While the reason for this discrepancy is unclear; it may be that the newly formed bone in response to vibration is not fully mineralized or of lower quality such that significant improvements in mechanical stability are not realized. Later, at 8 weeks, vibration caused an increase in BV/TV as detected by µCT and histologic evaluations. However, similar to the 4-week point there was no difference in mechanical stability of the vibration group relative to the control group at 8 weeks. These findings confirm the marginal benefits to implant-bone mechanical stability resulting from vibration stimulation\[[@ref43]-[@ref47]\]. Nevertheless, vibration may aid in maintaining or increasing peri-implant bone volume during the rehabilitation period, while the bone is not fully loaded.

Combined treatment of LIPUS and locally applied vibration did not demonstrate an improved 8-week osseointegration. Contrary to expectations, combining LIPUS and vibration resulted in decreased bone-implant stiffness relative to the LIPUS only. Axial loads to failure, however, were not affected by the combination of LIPUS and vibration compared to LIPUS only. Experimentally, fibrous collagen tissue stiffness is two orders of magnitude lower than cancellous bone\[[@ref48]\]. However, it is unclear whether the reduced bone-implant stiffness was due to fibrous encapsulation or to the presence of cancellous bone that had not fully mineralized.

This study had limitations. Reaching the apparent mechanical limits of the bone-implant interface around 4 weeks was not anticipated and, in an attempt, to reduce the number of animals used in this study, combined treatment effects were only investigated for osseointegration at 8 weeks. Because the mechanism of bone healing through vibration and LIPUS is not fully understood, a cumulative osseointegration benefit at 4 weeks with combined treatments of LIPUS and vibration may still be realized and should be investigated.

Also, the long-term mechanical or peri-implant bone benefits of the increased BV/TV and BIC seen at 8 weeks from locally applied vibration treatments were not investigated. Whether these increases persist after the end of the treatment period and what their long-term effects are on mechanical stability as the newly formed peri-implant bone matures should be investigated.

As the primary target for percutaneous osseointegrated implants are healthy and active trauma amputees\[[@ref2],[@ref49]\], we utilized a retired breeder female rat model to simulate an adult bone model. Female animals were used to allow comparison to ovariectomized (OVX) rat model studies that have been utilized to study postmenopausal osteoporosis and the effects of vibration on preventing such bone loss. However, we felt the OVX model was not a necessary model for our target clinical population because we did not intend to study the response of osteoporotic bone to therapy.

Finally, the AM implants were designed to fit a range of intramedullary canals without concern for the axial orientation of the implant during surgical placement to facilitate mass production and ease of surgery. A key benefit of using AM implants is that they can be customized to match patient specific anatomy. In a clinical environment, the implant could be designed to more closely interface with the endosteal surface which may affect the bone healing response to treatments and the resulting mechanical stability as studies suggested vibration primarily affects cancellous bone and the endosteal surfaces by acting on osteoblasts or precursor cells\[[@ref50]\].

Conclusion {#sec1-5}
==========

Vibration demonstrated improved peri-implant bone volume with increased BIC. LIPUS was superior to vibration for accelerating osseointegration at 4 weeks through increased axial force for bone-implant interface failure. LIPUS enhances early bone ongrowth potentially stabilizing future constructs allowing for accelerated implant loading with a reduced likelihood of fibrous ingrowth. LIPUS can be used as a therapeutic tool for possibly reducing the rehabilitation period of direct skeletal limb prostheses. The osseointegration benefits of LIPUS were no longer present at 8 weeks as the native biological ingrowth process appeared to catch up. However, vibration therapy continued to increase the amount of bone around the implant without affecting the mechanical properties of the bone-implant interface. Vibration has demonstrated its therapeutic benefits for increasing bone adjacent to the implant.
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